These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 18642944)
1. Glycoproteomic analyses of ovarian cancer cell lines and sera from ovarian cancer patients show distinct glycosylation changes in individual proteins. Li B; An HJ; Kirmiz C; Lebrilla CB; Lam KS; Miyamoto S J Proteome Res; 2008 Sep; 7(9):3776-88. PubMed ID: 18642944 [TBL] [Abstract][Full Text] [Related]
2. A glycomics approach to the discovery of potential cancer biomarkers. An HJ; Lebrilla CB Methods Mol Biol; 2010; 600():199-213. PubMed ID: 19882130 [TBL] [Abstract][Full Text] [Related]
3. Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. An HJ; Miyamoto S; Lancaster KS; Kirmiz C; Li B; Lam KS; Leiserowitz GS; Lebrilla CB J Proteome Res; 2006 Jul; 5(7):1626-35. PubMed ID: 16823970 [TBL] [Abstract][Full Text] [Related]
4. Methods in enzymology: O-glycosylation of proteins. Peter-Katalinić J Methods Enzymol; 2005; 405():139-71. PubMed ID: 16413314 [TBL] [Abstract][Full Text] [Related]
5. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; Vitonis A; Edwards D; Sluss P; Han WK; Berkowitz RS; Cramer DW Clin Cancer Res; 2006 Jan; 12(2):432-41. PubMed ID: 16428483 [TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of glycosylation: structural determination of N- and O-linked glycans by mass spectrometry. Harvey DJ Expert Rev Proteomics; 2005 Jan; 2(1):87-101. PubMed ID: 15966855 [TBL] [Abstract][Full Text] [Related]
7. N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis. Zhao J; Qiu W; Simeone DM; Lubman DM J Proteome Res; 2007 Mar; 6(3):1126-38. PubMed ID: 17249709 [TBL] [Abstract][Full Text] [Related]
8. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma. Hongsachart P; Huang-Liu R; Sinchaikul S; Pan FM; Phutrakul S; Chuang YM; Yu CJ; Chen ST Electrophoresis; 2009 Apr; 30(7):1206-20. PubMed ID: 19294700 [TBL] [Abstract][Full Text] [Related]
9. Glycoproteomics of N-glycosylation by in-gel deglycosylation and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry mapping: application to congenital disorders of glycosylation. Sagi D; Kienz P; Denecke J; Marquardt T; Peter-Katalinić J Proteomics; 2005 Jul; 5(10):2689-701. PubMed ID: 15912511 [TBL] [Abstract][Full Text] [Related]
10. Glycosylation status of the membrane protein CD9P-1. André M; Morelle W; Planchon S; Milhiet PE; Rubinstein E; Mollicone R; Chamot-Rooke J; Le Naour F Proteomics; 2007 Nov; 7(21):3880-95. PubMed ID: 17960739 [TBL] [Abstract][Full Text] [Related]
11. The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans. Chandrasekaran EV; Xue J; Neelamegham S; Matta KL Carbohydr Res; 2006 Jun; 341(8):983-94. PubMed ID: 16545347 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer. Gunawardana CG; Kuk C; Smith CR; Batruch I; Soosaipillai A; Diamandis EP J Proteome Res; 2009 Oct; 8(10):4705-13. PubMed ID: 19663500 [TBL] [Abstract][Full Text] [Related]
14. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer. Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522 [TBL] [Abstract][Full Text] [Related]
15. Proteomic studies of early-stage and advanced ovarian cancer patients. Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221 [TBL] [Abstract][Full Text] [Related]
16. Characterization of serum biomarkers for detection of early stage ovarian cancer. Kozak KR; Su F; Whitelegge JP; Faull K; Reddy S; Farias-Eisner R Proteomics; 2005 Nov; 5(17):4589-96. PubMed ID: 16237736 [TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1. Moshkovskii SA; Serebryakova MV; Kuteykin-Teplyakov KB; Tikhonova OV; Goufman EI; Zgoda VG; Taranets IN; Makarov OV; Archakov AI Proteomics; 2005 Sep; 5(14):3790-7. PubMed ID: 16121334 [TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Saldova R; Royle L; Radcliffe CM; Abd Hamid UM; Evans R; Arnold JN; Banks RE; Hutson R; Harvey DJ; Antrobus R; Petrescu SM; Dwek RA; Rudd PM Glycobiology; 2007 Dec; 17(12):1344-56. PubMed ID: 17884841 [TBL] [Abstract][Full Text] [Related]
19. [Identification of new ovarian cancer biomarkers with proteomic analyses--the diagnostic tool of the future?]. Petri AL; Høgdall E; Engelholm SA; Christensen IJ; Kjaer SK; Høgdall CK Ugeskr Laeger; 2007 Aug; 169(33):2614-9. PubMed ID: 17725906 [TBL] [Abstract][Full Text] [Related]
20. N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin. Machado E; Kandzia S; Carilho R; Altevogt P; Conradt HS; Costa J Glycobiology; 2011 Mar; 21(3):376-86. PubMed ID: 21030537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]